NCT03519308 2024-03-15A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic CancerAbramson Cancer Center at Penn MedicinePhase EARLY_PHASE1 Terminated3 enrolled 13 charts